Skip to main content
. 2014 May 9;30(11):1085–1102. doi: 10.1002/cnm.2645

Figure 2.

Figure 2

Model simulations of the normalised variation in the concentrations of osteoblast precursors, active osteoblasts, active osteoclasts and active tumour cells with respect to their respective initial values (multiple myeloma (MM) cells are injected at day 201 and removed at day 1001).